INOVIO PHARMACEUTICALS, INC. Available-for-sale Securities, Amortized Cost Basis
INOVIO PHARMACEUTICALS, INC. (INO) had Available-for-sale Securities, Amortized Cost Basis of $103.99 million as of 2017-12-31, per its 10-K filed 2019-03-12.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecuritiesAmortizedCost · last filed 2019-03-12
- 2017-12-31: Available-for-sale Securities, Amortized Cost Basis $103.99M.
- 2017-09-30: Available-for-sale Securities, Amortized Cost Basis $118.68M.
- 2017-06-30: Available-for-sale Securities, Amortized Cost Basis $68.20M.
- 2017-03-31: Available-for-sale Securities, Amortized Cost Basis $66.91M.
| Period end | Available-for-sale Securities, Amortized Cost Basis |
|---|---|
| 2017-12-31 | $103.99M 10-K · filed 2019-03-12 |
| 2017-09-30 | $118.68M 10-Q · filed 2017-11-08 |
| 2017-06-30 | $68.20M 10-Q · filed 2017-08-08 |
| 2017-03-31 | $66.91M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $85.98M 10-K · filed 2018-03-14 |
| 2016-09-30 | $96.28M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $105.78M 10-Q · filed 2016-08-08 |
| 2016-03-31 | $105.18M 10-Q · filed 2016-05-09 |
| 2015-12-31 | $105.60M 10-K · filed 2017-03-15 |
| 2015-09-30 | $85.73M 10-Q · filed 2015-11-09 |
| 2015-06-30 | $84.62M 10-Q · filed 2015-08-10 |
| 2015-03-31 | $55.06M 10-Q · filed 2015-05-11 |
| 2014-12-31 | $53.33M 10-K · filed 2016-03-14 |
| 2014-09-30 | $30.37M 10-Q · filed 2014-11-10 |
| 2014-06-30 | $20.37M 10-Q · filed 2014-08-11 |
| 2014-03-31 | $18.08M 10-Q · filed 2014-05-12 |
| 2013-12-31 | $18.98M 10-K · filed 2015-03-16 |
| 2013-09-30 | $13.19M 10-Q · filed 2013-11-12 |
| 2013-06-30 | $13.19M 10-Q · filed 2013-08-09 |
| 2013-03-31 | $7.90M 10-Q · filed 2013-05-10 |
| 2012-12-31 | $7.95M 10-K · filed 2014-03-17 |
| 2012-09-30 | $10.46M 10-Q · filed 2012-11-07 |
| 2012-06-30 | $13.42M 10-Q · filed 2012-08-09 |
| 2011-12-31 | $12.83M 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |